title: Susceptibility to Measles Among Perinatally HIV-Infected Adolescents and Young Adults.
abstract: Among our cohort of adolescents and young adults with perinatally acquired human immunodeficiency virus, few (17.6%) had measles protective antibodies by plaque reduction neutralization (PRN). Agreement was demonstrated between the commercial enzyme immunoassay and the PRN assay (K = 0.59 [95% confidence interval: 0.23-0.95]). Further studies are needed to understand the determinants of immunity in this population.
authors.affiliation: Division of Pediatric Infectious Disease, Mount Sinai School of Medicine, New York, New York.
authors.forename: Lee E
authors.initials: LE
authors.lastname: Morris
authors.affiliation: Division of Pediatric Infectious Disease, Mount Sinai School of Medicine, New York, New York.
authors.forename: Roberto
authors.initials: R
authors.lastname: Posada
authors.affiliation: Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Carole J
authors.initials: CJ
authors.lastname: Hickman
authors.affiliation: Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Donald R
authors.initials: DR
authors.lastname: Latner
authors.affiliation: Department of OB/Gyn.
authors.forename: Tricia A
authors.initials: TA
authors.lastname: Singh
authors.affiliation: Department of OB/Gyn.
authors.forename: Alyssa
authors.initials: A
authors.lastname: Rautenberg
authors.affiliation: Department of OB/Gyn Division of Infectious Disease, Mount Sinai School of Medicine, New York, New York.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Jao
authors.affiliation: Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: William J
authors.initials: WJ
authors.lastname: Bellini
authors.affiliation: Department of OB/Gyn.
authors.forename: Rhoda
authors.initials: R
authors.lastname: Sperling
mesh_terms: D000293:Adolescent; D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D015331:Cohort Studies; D004198:Disease Susceptibility; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology*; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008457:Measles / Q000453:epidemiology* / Q000276:immunology*; D055815:Young Adult
chemical_list: D044966:Anti-Retroviral Agents
keywords: HIV; adolescents; measles immunity; perinatally acquired HIV infection.
references.citation: Pediatr Infect Dis J. 2009 Apr;28(4):295-9
references.pmid: 19258919
references.citation: Future Virol. 2011 Jan 1;6(1):59-71
references.pmid: 21339832
references.citation: J Infect Dis. 2011 Jul;204 Suppl 1:S164-78
references.pmid: 21666158
references.citation: Lancet Infect Dis. 2010 Sep;10(9):630-42
references.pmid: 20797645
references.citation: J Infect Dis. 1990 Nov;162(5):1036-42
references.pmid: 2230231
references.citation: Pediatrics. 2006 Aug;118(2):e315-22
references.pmid: 16847077
references.citation: Pediatrics. 2003 Jun;111(6 Pt 1):e641-4
references.pmid: 12777579
references.citation: J Infect Dis. 2011 Jul;204 Suppl 1:S179-89
references.pmid: 21666159
references.citation: J Virol Methods. 1981 Dec;3(5):251-60
references.pmid: 7334066
references.citation: J Clin Microbiol. 1995 Apr;33(4):811-5
references.pmid: 7790442
references.citation: MMWR Morb Mortal Wkly Rep. 2012 Apr 20;61:253-7
references.pmid: 22513526
references.citation: J Infect Dis. 2012 Aug 15;206(4):512-22
references.pmid: 22693229
references.citation: Clin Infect Dis. 2010 May 15;50(10):1415-8
references.pmid: 20377409